Open AccessP045 Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) in a Brazilian public healthcare clinic
Author(s) -
Lopes Marina,
Shintaku Daniel,
de Oliveira Ana Carolina,
Beraldo Rodrigo,
Godoi Giovana,
Castelhano Natalia,
Daniela Salate Biagioni Vulcano,
Pereira Jessica,
de Oliveira Ellen Cristina,
Herrerias Giedre,
Rogério Saad-Hossne,
Baima Julio,
Barbosa Walnei,
Giovanni Silva,
Lígia Yukie Sassaki
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000798780.14901.4e
Subject(s) - medicine , fatty liver , inflammatory bowel disease , disease , ulcerative colitis , gastroenterology , outpatient clinic , population , crohn's disease , incidence (geometry) , liver disease , environmental health , physics , optics
Inflammatory Bowel Disease (IBD) is an inflammatory and chronic disease, as well as non-alcoholic fatty liver disease (NAFLD). Current literature has shown that IBD patients are at high risk for NAFLD. In those patients, the pathogenesis of NAFLD may be more complex and related to multifactor causes, such as gut dysbiosis, unhealthy nutritional behavior, body composition and systemic inflammation. There is an increase in NAFLD's incidence in the general population, otherwise, there are few studies evaluating NAFLD prevalence in IBD patients. So, this study aimed to evaluate prevalence of NAFLD and identify the clinical factors associated with the presence of NAFLD in patients with IBD.